Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Follman GmbH & Co. Kg has 1 pending office action in the Chemistry & Materials technology area. This case is overseen by 1 distinct examiner and 1 distinct art unit, which concentrates the company's current office activity. This level of focus suggests that the company is prioritizing a specific chemical or material advancement in its active docket. The pending office action represents the current boundary of the company's patent prosecution efforts.
The busiest examiner for the company is MRUK, BRIAN P, who is assigned 1 busiest examiner pending office action. As this examiner manages the active matter, the company's prosecution progress relies on the specific feedback from this individual. Practitioners should analyze the examiner's history in the Chemistry & Materials sector to better anticipate potential rejections. The outcome of the 1 pending office action will determine the company's immediate success in securing new patent rights. Navigating the requirements of this specific official is the central task for the company's current legal strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MRUK, BRIAN P | 1 | 74.2% | +27.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009030 | IMPROVED MICROCAPSULES AND METHOD FOR THE PRODUCTION AND USE THEREOF | MRUK, BRIAN P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18009030 | IMPROVED MICROCAPSULES AND METHOD FOR THE PRODUCTION AND USE THEREOF | MRUK, BRIAN P | — |
| Art Unit | Apps |
|---|---|
| 1700 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18009030 | IMPROVED MICROCAPSULES AND METHOD FOR THE PRODUCTION AND USE THEREOF | MRUK, BRIAN P | 1700 | §102§103§112Other | Non-Final OA | — | Pending | Dec 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial